Martinez, GA, United States of America

Yanmei Tao


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Spotlight: Yanmei Tao – A Pioneer in ErbB2 Modulation

Introduction: Yanmei Tao, based in Martinez, GA, is an accomplished inventor and researcher known for his groundbreaking work in the field of biomedicine. With a patented innovation in methods and compositions for modulating ErbB2 activity, he is making significant strides in the treatment of various disorders associated with ErbB2 misregulation.

Latest Patents: Yanmei Tao holds a pivotal patent titled "Methods and compositions for modulating ErbB2 activity." This invention outlines a method that modulates the interaction between ErbB2 and Erbin, a strategy that has crucial implications for treating ErbB2-mediated disorders. Notably, the patent reveals that inhibiting the formation of heterodimers between Erbin and ErbB2 can reduce the biological activity of ErbB2, which is particularly beneficial for treating conditions such as breast cancer and prostate cancer. Furthermore, the invention suggests that creating agonists of Erbin could enhance its interaction with ErbB2, opening new avenues for addressing certain neurological disorders.

Career Highlights: Yanmei Tao is affiliated with the Medical College of Georgia Research Institute, Inc., where he contributes to pioneering research initiatives. His expertise in molecular biology and therapeutic applications has positioned him as a key player in the ongoing battle against cancers linked to ErbB2 overexpression.

Collaborations: Throughout his career, Yanmei has collaborated with esteemed colleagues, including Lin Mei and Wen-Chen Xiong. These collaborations have enriched his research and expanded the impact of his work in the scientific community, furthering the development of innovative solutions for complex health challenges.

Conclusion: Yanmei Tao exemplifies the spirit of innovation in the field of biotechnology through his contributions to ErbB2 modulation. His patented methods not only promise advancements in cancer treatment but also highlight the potential for neurological applications. As a dedicated researcher at the Medical College of Georgia Research Institute, Inc., Yanmei continues to pave the way for new therapeutic approaches, underscoring the importance of collaboration and creativity in scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…